雜志介紹

Diabetes Therapy雜志介紹

《Diabetes Therapy》是一本以English為主的開放獲取國際優秀期刊，中文名稱糖尿病治療，本刊主要出版、報道醫學-ENDOCRINOLOGY & METABOLISM領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為2.8，最新CiteScore 指數為6.9。

本刊近期中國學者發表的論文主要有：

• Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China

  Author: Liu, Lei; Ruan, Zhen; Ung, Carolina Oi Lam; Zhang, Yawen; Shen, Yang; Han, Sheng; Jia, Ruxu; Qiao, Jingtao; Hu, Hao; Guo, Lixin

• Application of the PDCA Cycle for Managing Hyperglycemia in Critically Ill Patients

  Author: Chen, Jie; Cai, Wenchao; Lin, Feng; Chen, Xiaochu; Chen, Rui; Ruan, Zhanwei

• Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Hypertensive and/or Diabetic People Aged over 60 Years: A Prospective Open-Label Study

  Author: Huang, Rongdong; Liu, Xiaoqin; Xie, Fangqin; Li, Junrong; Tang, Zhangbin; Wu, Yuying; Zhou, Peicong; Zhang, Dongjuan

• Risk Factors for Glycemic Control in Hospitalized Patients with Type 2 Diabetes Receiving Continuous Subcutaneous Insulin Infusion Therapy

  Author: Wang, Shun-hua; Shao, Wei; Jiang, Qiu-hui; Zheng, Xuan-ling; Shen, Qing-bao; Lin, Xiao-yan; Zhang, Qiao-qing; Zhang, Lu-lu; Shi, Xiu-lin; Wang, Wen-gui; Li, Xue-jun

英文介紹

Diabetes Therapy雜志英文介紹

Diabetes Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all areas of diabetes. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.

The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Diabetes Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.